Range of suitable clients: CDEC reviewed the uncertainty in the quantity of sufferers with moderately extreme to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific gurus consulted by CADTH indicated that some sufferers who're classified as owning delicate or average disorder could have a serious bleeding phenotype, which https://hemgenix93059.total-blog.com/hemgenix-secrets-61037600